{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T17:37:25Z","timestamp":1648834645313},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00108-019-0654-z","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T10:50:44Z","timestamp":1564743044000},"page":"912-916","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neue Technologien in der Diabetestherapie"],"prefix":"10.1007","volume":"60","author":[{"given":"Georg","family":"Serfling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannes","family":"Kalscheuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian M.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"issue":"12","key":"654_CR1","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1007\/s00125-012-2708-9","volume":"55","author":"T Battelino","year":"2012","unstructured":"Battelino\u00a0T et\u00a0al (2012) The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a\u00a0randomised controlled trial. Diabetologia 55(12):3155\u20133162","journal-title":"Diabetologia"},{"issue":"6","key":"654_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2337\/dc17-0133","volume":"40","author":"WH Polonsky","year":"2017","unstructured":"Polonsky\u00a0WH, Hessler\u00a0D, Ruedy\u00a0KJ, Beck\u00a0RW, DIAMOND Study Group (2017) The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial. Diabetes Care 40(6):736\u2013741","journal-title":"Diabetes Care"},{"issue":"10110","key":"654_CR3","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","volume":"390","author":"DS Feig","year":"2017","unstructured":"Feig\u00a0DS et\u00a0al (2017) Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a\u00a0multicentre international randomised controlled trial. lancet 390(10110):2347\u20132359","journal-title":"lancet"},{"issue":"10057","key":"654_CR4","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","volume":"388","author":"J Bolinder","year":"2016","unstructured":"Bolinder\u00a0J, Antuna\u00a0R, Geelhoed-Duijvestijn\u00a0P, Kr\u00f6ger\u00a0J, Weitgasser\u00a0R (2016) Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a\u00a0multicentre, non-masked, randomised controlled trial. Lancet 388(10057):2254\u20132263","journal-title":"Lancet"},{"key":"654_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13942","author":"P Avari","year":"2019","unstructured":"Avari\u00a0P, Reddy\u00a0M, Oliver\u00a0N (2019) Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a\u00a0discrete device (non-invasive or invasive)? Diabet Med J Br Diabet Assoc. \n                    https:\/\/doi.org\/10.1111\/dme.13942","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"5","key":"654_CR6","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2337\/dc15-1990","volume":"39","author":"Diabetes Control and Complications Trial (DCCT)","year":"2016","unstructured":"Diabetes Control and Complications Trial (DCCT), Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up. Diabetes Care 39(5):686\u2013693","journal-title":"Diabetes Care"},{"issue":"14","key":"654_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"Diabetes Control and Complications Trial Research Group et al (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N\u00a0Engl J Med 329(14):977\u2013986","journal-title":"N Engl J Med"},{"key":"654_CR8","first-page":"CD005103","volume":"1","author":"ML Misso","year":"2010","unstructured":"Misso\u00a0ML, Egberts\u00a0KJ, Page\u00a0M, O\u2019Connor\u00a0D, Shaw\u00a0J (2010) Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 1:CD5103","journal-title":"Cochrane Database Syst Rev"},{"issue":"7339","key":"654_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/bmj.324.7339.705","volume":"324","author":"J Pickup","year":"2002","unstructured":"Pickup\u00a0J, Mattock\u00a0M, Kerry\u00a0S (2002) Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 324(7339):705","journal-title":"BMJ"},{"issue":"9","key":"654_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1463-1326.2012.01580.x","volume":"14","author":"PD Home","year":"2012","unstructured":"Home\u00a0PD (2012) The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences. Diabetes Obes Metab 14(9):780\u2013788","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"654_CR11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s40262-016-0473-5","volume":"56","author":"T Heise","year":"2017","unstructured":"Heise\u00a0T et al (2017) Pharmacokinetic and Pharmacodynamic properties of faster-acting insulin Aspart versus insulin Aspart across a\u00a0clinically relevant dose range in subjects with type 1 diabetes mellitus. Clin Pharmacokinet 56(6):649\u2013660","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"654_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1932296814554797","volume":"9","author":"A Basu","year":"2015","unstructured":"Basu\u00a0A et\u00a0al (2015) Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes. J\u00a0Diabetes Sci Technol 9(1):63\u201368","journal-title":"J Diabetes Sci Technol"},{"issue":"13","key":"654_CR13","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1001\/jama.2016.11708","volume":"316","author":"RM Bergenstal","year":"2016","unstructured":"Bergenstal\u00a0RM et al (2016) Safety of a\u00a0hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 316(13):1407\u20131408","journal-title":"JAMA"},{"issue":"3","key":"654_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1089\/dia.2016.0421","volume":"19","author":"SK Garg","year":"2017","unstructured":"Garg\u00a0SK et al (2017) Glucose outcomes with the in-home use of a\u00a0hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther 19(3):155\u2013163","journal-title":"Diabetes Technol Ther"},{"key":"654_CR15","doi-asserted-by":"publisher","first-page":"k1310","DOI":"10.1136\/bmj.k1310","volume":"361","author":"E Bekiari","year":"2018","unstructured":"Bekiari\u00a0E et al (2018) Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ 361:k1310","journal-title":"BMJ"},{"issue":"3","key":"654_CR16","first-page":"1269","volume":"9","author":"X Dai","year":"2018","unstructured":"Dai\u00a0X, Luo\u00a0Z\u2011C, Zhai\u00a0L, Zhao\u00a0W\u2011P, Huang\u00a0F (2018) Artificial pancreas as an effective and safe alternative in patients with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetes Ther Res Treat Educ Diabetes Relat Disord 9(3):1269\u20131277","journal-title":"Diabetes Ther Res Treat Educ Diabetes Relat Disord"},{"issue":"7","key":"654_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S2213-8587(17)30167-5","volume":"5","author":"A Weisman","year":"2017","unstructured":"Weisman\u00a0A, Bai\u00a0J\u2011W, Cardinez\u00a0M, Kramer\u00a0CK, Perkins\u00a0BA (2017) Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a\u00a0systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol 5(7):501\u2013512","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10155","key":"654_CR18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(18)31947-0","volume":"392","author":"M Tauschmann","year":"2018","unstructured":"Tauschmann\u00a0M et al (2018) Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a\u00a0multicentre, 12-week randomised trial. Lancet 392(10155):1321\u20131329","journal-title":"Lancet"},{"issue":"7","key":"654_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1602494","volume":"375","author":"ZA Stewart","year":"2016","unstructured":"Stewart\u00a0ZA et al (2016) Closed-loop insulin delivery during pregnancy in women with type 1 diabetes. N\u00a0Engl J Med 375(7):644\u2013654","journal-title":"N Engl J Med"},{"issue":"7","key":"654_CR20","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2337\/dc18-0228","volume":"41","author":"JR Castle","year":"2018","unstructured":"Castle\u00a0JR et al (2018) Randomized outpatient trial of single- and dual-hormone closed-loop systems that adapt to exercise using wearable sensors. Diabetes Care 41(7):1471\u20131477","journal-title":"Diabetes Care"},{"issue":"12","key":"654_CR21","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1007\/s00125-016-4107-0","volume":"59","author":"N Taleb","year":"2016","unstructured":"Taleb\u00a0N et al (2016) Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial. Diabetologia 59(12):2561\u20132571","journal-title":"Diabetologia"},{"issue":"8","key":"654_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/dia.2016.0043","volume":"18","author":"V Gingras","year":"2016","unstructured":"Gingras\u00a0V, Haidar\u00a0A, Messier\u00a0V, Legault\u00a0L, Ladouceur\u00a0M, Rabasa-Lhoret\u00a0R (2016) A simplified Semiquantitative meal bolus strategy combined with single- and dual-hormone closed-loop delivery in patients with type 1 diabetes: a pilot study. Diabetes Technol Ther 18(8):464\u2013471","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"654_CR23","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1210\/jc.2013-4151","volume":"99","author":"FH El-Khatib","year":"2014","unstructured":"El-Khatib\u00a0FH et al (2014) Autonomous and continuous adaptation of a\u00a0bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J\u00a0Clin Endocrinol Metab 99(5):1701\u20131711","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"654_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.diabres.2012.10.024","volume":"99","author":"AS Brazeau","year":"2013","unstructured":"Brazeau\u00a0AS et\u00a0al (2013) Carbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes. Diabetes Res Clin Pract 99(1):19\u201323","journal-title":"Diabetes Res Clin Pract"},{"key":"654_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13810","author":"A Melmer","year":"2019","unstructured":"Melmer\u00a0A, Z\u00fcger\u00a0T, Lewis\u00a0DM, Leibrand\u00a0S, Stettler\u00a0C, Laimer\u00a0M (2019) Glycemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS). Diabetes Obes Metab. \n                    https:\/\/doi.org\/10.1111\/dom.13810","journal-title":"Diabetes Obes Metab"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0654-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-019-0654-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0654-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T09:23:42Z","timestamp":1596273822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-019-0654-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1007\/s00108-019-0654-z","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,2]]},"assertion":[{"value":"2 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"G.\u00a0Serfling, H.\u00a0Kalscheuer, S.M.\u00a0Schmid und H.\u00a0Lehnert geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}